Janky E, Leng J J, Cormier P H, Salamon R, Meynard J
Service de Gynécologie, Hôpital Pellegrin, Bordeaux.
J Gynecol Obstet Biol Reprod (Paris). 1990;19(4):478-82.
The authors compare the efficiency of two drugs in the treatment of threatened premature labour, the one being the calcium inhibitor (nifedipine) and the other a beta-mimetic drug (ritodrine). 62 patients after random selection were divided into two groups: 32 treated with ritodrine and 30 treated with nifedipine. The treatment was carried out over 7 days. The success rate was similar in both groups -72% for the ritodrine group and 63.33% for the nifedipine group. Women receiving nifedipine had slightly greater gain in weeks, six as against five for ritodrine. The side effects which were often found with nifedipine were; hot flushes (in 10 cases) and headaches (4 cases). These symptoms appeared 15-30 minutes after the first dose and were transitory. No neonatal complications were found. The ease with which a calcium inhibitor can be given suggests that it should be used more frequently in the treatment of threatened premature labour and particularly when there are contra-indications to the use of beta-mimetic drugs.
作者比较了两种药物治疗先兆早产的效果,一种是钙抑制剂(硝苯地平),另一种是β-拟交感神经药物(利托君)。随机选择62例患者分为两组:32例接受利托君治疗,30例接受硝苯地平治疗。治疗持续7天。两组成功率相似——利托君组为72%,硝苯地平组为63.33%。接受硝苯地平治疗的女性孕周增加略多,硝苯地平组增加6周,利托君组增加5周。硝苯地平常见的副作用有:潮热(10例)和头痛(4例)。这些症状在首剂给药后15 - 30分钟出现,且为一过性。未发现新生儿并发症。钙抑制剂给药简便,表明其在先兆早产治疗中应更频繁使用,尤其是在有使用β-拟交感神经药物禁忌证的情况下。